Jugend und Freizeit: Forschungsbericht über eine Studie zum Freizeitverhalten ; Kurzfassung

Die Studie untersucht das Freizeitverhalten Jugendlicher in einer Kleinstadt in der DDR. Ihr Ziel ist es, den für die Führung der Jugendpolitik verantwortlichen Führungskräften wissenschaftlich fundierte Angaben über den Inhalt der Freizeit Jugendlicher zur Verfügung zu stellen. Im Unterschied zu ähnlichen Studien aus der DDR werden hier Jugendliche aus einer typischen Kleinstadt (Grimma, 17000 Einwohner) untersucht, von denen es etwa 200 ähnlicher Größenordnung gibt und in denen etwa 25 Prozent der Gesamtbevölkerung lebt (1967). Neben der allgemeinen Analyse der Freizeitinteressen, der Freizeitwünsche und des realen Freizeitverhaltens ist die Studie auf die Erforschung der folgenden drei Fragenkomplexe gerichtet: (1) Einfluß des sozialistischen Jugendverbandes auf das Freizeitverhalten (2) Soziale Kontaktformen (Freizeitpartner) (3) Einfluß der Massenkommunikationsmittel auf das Freizeitverhalten. (zä2

Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma

Despite advancements in lowering blood pressure, the best approach to lower it remains controversial because of the lack of information on the molecular basis of hypertension. We, therefore, performed plasma proteomics of plasma from patients with hypertension to identify molecular determinants detectable in these subjects but not in controls and vice versa. Plasma samples from hypertensive subjects (cases; n=118) and controls (n=85) from the InGenious HyperCare cohort were used for this study and performed mass spectrometric analysis. Using biostatistical methods, plasma peptides specific for hypertension were identified, and a model was developed using least absolute shrinkage and selection operator logistic regression. The underlying peptides were identified and sequenced off-line using matrix-assisted laser desorption ionization orbitrap mass spectrometry. By comparison of the molecular composition of the plasma samples, 27 molecular determinants were identified differently expressed in cases from controls. Seventy percent of the molecular determinants selected were found to occur less likely in hypertensive patients. In cross-validation, the overall R(2) was 0.434, and the area under the curve was 0.891 with 95% confidence interval 0.8482 to 0.9349, P<0.0001. The mean values of the cross-validated proteomic score of normotensive and hypertensive patients were found to be -2.007±0.3568 and 3.383±0.2643, respectively, P<0.0001. The molecular determinants were successfully identified, and the proteomic model developed shows an excellent discriminatory ability between hypertensives and normotensives. The identified molecular determinants may be the starting point for further studies to clarify the molecular causes of hypertension

The European language technology landscape in 2020: Language-centric and human-centric AI for cross-cultural communication in multilingual Europe

Multilingualism is a cultural cornerstone of Europe and firmly anchored in the European treaties including full language equality. However, language barriers impacting business, cross-lingual and cross-cultural communication are still omnipresent. Language Technologies (LTs) are a powerful means to break down these barriers. While the last decade has seen various initiatives that created a multitude of approaches and technologies tailored to Europe’s specific needs, there is still an immense level of fragmentation. At the same time, AI has become an increasingly important concept in the European Information and Communication Technology area. For a few years now, AI – including many opportunities, synergies but also misconceptions – has been overshadowing every other topic. We present an overview of the European LT landscape, describing funding programmes, activities, actions and challenges in the different countries with regard to LT, including the current state of play in industry and the LT market. We present a brief overview of the main LT-related activities on the EU level in the last ten years and develop strategic guidance with regard to four key dimensions.publishedVersio

Bewertung der Umsetzung des SGB II aus gleichstellungspolitischer Sicht: Abschlussbericht

Die Untersuchung zeigt, dass Ansätze zur Gleichstellung der Geschlechter am Arbeitsmarkt in der bisherigen Umsetzungspraxis des SGB II eine geringe Rolle spielten. Trotz anhaltender geschlechtsspezifischer Ungleichheiten auf dem Arbeitsmarkt existierte nur eine insgesamt schwach ausgeprägte gleichstellungspolitische Steuerung, der zudem Rahmenbedingungen (u. a. knappe personelle Ressourcen und Priorisierung von Effektivitäts- und Effizienzzielen) gegenüber standen, die dem Nachteilsausgleich auf operativer Ebene enge Grenzen setzten. Positive Beispiele beruhten oft auf dem Engagement einzelner Fach- und Führungskräfte oder externen Anstößen. Durch ein insgesamt stärkeres Fördern und Fordern von Männern wurden damit tendenziell eher tradierte Rollenmuster und geschlechtsspezifische Integrationswege stabilisiert, statt diesen aktiv entgegen zu wirken

European Language Grid: A Joint Platform for the European Language Technology Community

Europe is a multilingual society, in which dozens of languages are spoken. The only option to enable and to benefit from multilingualism is through Language Technologies (LT), i.e., Natural Language Processing and Speech Technologies. We describe the European Language Grid (ELG), which is targeted to evolve into the primary platform and marketplace for LT in Europe by providing one umbrella platform for the European LT landscape, including research and industry, enabling all stakeholders to upload, share and distribute their services, products and resources. At the end of our EU project, which will establish a legal entity in 2022, the ELG will provide access to approx. 1300 services for all European languages as well as thousands of data sets

European Language Grid: An Overview

With 24 official EU and many additional languages, multilingualism in Europe and an inclusive Digital Single Market can only be enabled through Language Technologies (LTs). European LT business is dominated by hundreds of SMEs and a few large players. Many are world-class, with technologies that outperform the global players. However, European LT business is also fragmented – by nation states, languages, verticals and sectors, significantly holding back its impact. The European Language Grid (ELG) project addresses this fragmentation by establishing the ELG as the primary platform for LT in Europe. The ELG is a scalable cloud platform, providing, in an easy-to-integrate way, access to hundreds of commercial and non-commercial LTs for all European languages, including running tools and services as well as data sets and resources. Once fully operational, it will enable the commercial and non-commercial European LT community to deposit and upload their technologies and data sets into the ELG, to deploy them through the grid, and to connect with other resources. The ELG will boost the Multilingual Digital Single Market towards a thriving European LT community, creating new jobs and opportunities. Furthermore, the ELG project organises two open calls for up to 20 pilot projects. It also sets up 32 national competence centres and the European LT Council for outreach and coordination purposes

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries